Innovation in Central Venous Access Device Security: A Pilot Randomized Controlled Trial in Pediatric Critical Care

Pediatric Critical Care Medicine

Volumn 20, Issue 10, 2019, Pages E480-E488

  Ullman, Amanda J ^a,b,c   Long, Debbie ^a,c   Williams, Tara ^c   Pearson, Kylie ^c   Mihala, Gabor ^a,d   Mattke, Adrian C ^c,e   Macfarlane, Fiona ^c,e   Rickard, Claire M ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c QUEENSLAND CHILDREN S HOSPITAL   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Central; Critical care; Dressing; Evidence based care; Pediatrics; Site care; Vascular access

Indexed keywords

CHLORHEXIDINE GLUCONATE; TISSUE ADHESIVE;

ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHICS; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; PEDIATRIC HOSPITAL; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TERTIARY CARE CENTER; ADVERSE DEVICE EFFECT; ADVERSE EVENT; BANDAGE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; DEVICE FAILURE; EVIDENCE BASED PRACTICE; FEASIBILITY STUDY; PEDIATRIC INTENSIVE CARE UNIT; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PROCEDURES; THROMBOSIS;

BANDAGES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; CHILD, PRESCHOOL; CRITICAL CARE; EQUIPMENT FAILURE; EVIDENCE-BASED PRACTICE; FEASIBILITY STUDIES; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; TISSUE ADHESIVES;

EID: 85072903325     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000002059     Document Type: Article

References (39)

1. Ullman AJ, Cooke M, Kleidon T, et al: Road map for improvement: Point prevalence audit and survey of central venous access devices in paediatric acute care. J Paediatr Child Health 2017; 53:123–130
2. Bezzio S, Scolfaro C, Broglia R, et al: Prospective incidence study of bloodstream infection in infants and children with central venous catheters after cardiac surgery in Italy. Infect Control Hosp Epidemiol 2009; 30:698–701
3. Gilbert RE, Mok Q, Dwan K, et al: Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): A randomised controlled trial. Lancet 2016; 387:1732–1742
4. Ullman AJ, Marsh N, Mihala G, et al: Complications of central venous access devices: A systematic review. Pediatrics 2015; 136:e1331–e1344
5. Rickard CM, Ullman AJ: Bloodstream infection and occlusion of central venous catheters in children. Lancet Infect Dis 2018; 18:815–817
6. Ullman AJ, Cooke ML, Mitchell M, et al: Dressings and securement devices for central venous catheters (CVC). Cochrane Database Syst Rev 2015; 9:Cd010367
7. Choong K, Awladthani S, Khawaji A, et al: Early exercise in critically ill youth and children, a preliminary evaluation: The wEECYCLE pilot trial. Ped Crit Care Med 2017; 18:e546–e554
8. Rickard CM, Edwards M, Spooner AJ, et al: A 4-arm randomized controlled pilot trial of innovative solutions for jugular central venous access device securement in 221 cardiac surgical patients. J Crit Care 2016; 36:35–42
9. Kleidon TM, Ullman AJ, Gibson V, et al: A pilot randomized controlled trial of novel dressing and securement techniques in 101 pediatric patients. J Vasc Interv Radiol 2017; 28:1548.e1–1556.e1
10. Ullman AJ, Kleidon T, Gibson V, et al: Innovative dressing and securement of tunneled central venous access devices in pediatrics: A pilot randomized controlled trial. BMC Cancer 2017; 17:595
11. Chan RJ, Northfield S, Larsen E, et al: Central venous access device securement and dressing effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): A pilot randomised controlled trial. Trials 2017; 18:458
12. Ullman AJ, Kleidon T, Gibson V, et al: Central venous access device securement and dressing effectiveness (CASCADE) in paediatrics: Protocol for randomised controlled trials. BMJ Open 2016; 6:e011197
13. Hertzog MA: Considerations in determining sample size for pilot studies. Res Nurs Health 2008; 31:180–191
14. Lancaster GA, Dodd S, Williamson PR: Design and analysis of pilot studies: Recommendations for good practice. J Eval Clin Pract 2004; 10:307–312
15. Thabane L, Ma J, Chu R, et al: A tutorial on pilot studies: The what, why and how. BMC Med Res Meth 2010; 10:1
16. Centers for Disease Control and Prevention and National Healthcare Safety Network: July 2013 CDC/NHSN Prevention: Device associated module: CLABSI. Atlanta, GA, National Healthcare Safety Network, 2014, pp 1–19
17. Yamamoto AJ, Solomon JA, Soulen MC, et al: Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol 2002; 13:77–81
18. Goossens GA, De Waele Y, Jérôme M, et al: Diagnostic accuracy of the catheter injection and aspiration (CINAS) classification for assessing the function of totally implantable venous access devices. Support Care Cancer 2016; 24:755–761
19. Fratino G, Molinari AC, Parodi S, et al: Central venous catheter-related complications in children with oncological/hematological diseases: An observational study of 418 devices. Ann Oncol 2005; 16:648–654
20. O’Grady N, Alexander M, Burns L, et al: Guidelines for the prevention of intravascular catheter-related infections. Clinical Infectious Diseases 2011; 52:1087–1099
21. Broadhurst D, Moureau N, Ullman AJ: Management of central venous access device-associated skin impairment: An evidence-based algorithm. J Wound Ostomy Continence Nurs 2017; 44:211–220
22. Cecinati V, Brescia L, Tagliaferri L, et al: Catheter-related infections in pediatric patients with cancer. Eur J Clin Microbiol Infect Dis 2012; 31:2869–2877
23. Reichman D, Greenberg J: Reducing surgical site infections: A review. Rev Obst Gyn 2009; 2:212–221
24. Advani S, Reich NG, Sengupta A, et al: Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: Extending risk analyses outside the intensive care unit. Clin Infect Dis 2011; 52:1108–1115
25. Robinson JL, Casey LM, Huynh HQ, et al: Prospective cohort study of the outcome of and risk factors for intravascular catheter-related bloodstream infections in children with intestinal failure. JPEN J Parenter Enteral Nutr 2014; 38:625–630
26. Lorente L, Huidobro MS, Martín MM, et al: Accidental catheter removal in critically ill patients: A prospective and observational study. Crit Care 2004; 8:R229–R233
27. Jumani K, Advani S, Reich NG, et al: Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr 2013; 167:429–435
28. Children’s Health Services: CVAD Insertion and Management. Brisbane, Oceania, Queensland Government, 2014
29. Craig P, Dieppe P, Macintyre S, et al: Medical Research Council Guidance: Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ 2008; 337:a1655
30. Goossens GA, Grumiaux N, Janssens C, et al: SecurAstaP trial: Securement with securacath versus statlock for peripherally inserted central catheters, a randomised open trial. BMJ Open 2018; 8:e016058
31. Takashima M, Schults J, Mihala G, et al: Complication and failures of central vascular access device in adult critical care settings. Crit Care Med 2018; 46:1998–2009
32. Athale UH, Siciliano S, Cheng J, et al: Central venous line dysfunction is an independent predictor of poor survival in children with cancer. J Pediatr Hematol Oncol 2012; 34:188–193
33. Edwards JD, Herzig CT, Liu H, et al: Central line-associated blood stream infections in pediatric intensive care units: Longitudinal trends and compliance with bundle strategies. Am J Infect Control 2015; 43:489–493
34. Simonova G, Rickard CM, Dunster KR, et al: Cyanoacrylate tissue adhesives - effective securement technique for intravascular catheters: In vitro testing of safety and feasibility. Anaesth Intensive Care 2012; 40:460–466
35. Rickard CM, Marsh N, Webster J, et al: Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): A pragmatic, randomised controlled, superiority trial. Lancet 2018; 392:419–430
36. Rickard CM, Marsh NM, Webster J, et al: Peripherally inserted central catheter dressing and securement in patients with cancer: The PISCES trial. protocol for a 2x2 factorial, superiority randomised controlled trial. BMJ Open 2017; 7:e015291
37. Timsit JF, Bouadma L, Ruckly S, et al: Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med 2012; 40:1707–1714
38. Wilson MZ, Rafferty C, Deeter D, et al: Attributable costs of central line-associated bloodstream infections in a pediatric hematology/oncology population. Am J Infect Control 2014; 42:1157–1160
39. Ullman AJ, Kleidon T, Cooke M, et al: Substantial harm associated with failure of chronic paediatric central venous access devices. BMJ Case Reports 2017; 2017. pii: bcr-2016-218757